Julphar achieved consistent growth in sales and stable profits during the first nine months
Ras Al Khaimah, November 13 / WAM / Gulf Pharmaceutical Industries Company, Julphar, recorded a strong performance during the third quarter, as its net revenues reached 249.7 million dirhams, a growth of 5%, bringing revenues during the first nine months to 796.1 million dirhams, an increase of 5.8%, while the earnings before interest, taxes, depreciation and amortization (EBITDA) index rose to 108.7 million dirhams compared to 80.5 million dirhams in the same period last year.
According to the financial results for the third quarter and the nine months ending in September 2025, net income turned positive to reach 36.7 million dirhams after it was 9.9 million dirhams last year.
This performance was a result of the company’s commitment to achieving cost efficiency and operational discipline, which was reflected in enhancing the profitability of ongoing operations and improving profit margins.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
